Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive pathogens, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), streptococci and enterococci.

ComASP® (Compact Antimicrobial Susceptibility Panel) Oritavancin is a 2-test panel containing the dried up antibiotic in 15 two-fold dilutions (0.001-16 μg/ml).

ComASP® Oritavancin is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO 20776-1:2006).

Choose among one of the following nine preset panels or request customized 32-well panel formats with over 100 antibiotics available:

  • Oritavancin
  • Colistin
  • Piperacillin-tazobactam
  • Colistin / Piperacillin-tazobactam
  • Ceftolozane-tazobactam / Ceftazidime-avibactam
  • Vancomycin / Teicoplanin
  • Ceftolozane-tazobactam
  • Vancomycin
  • Antifungal